CONTACT US

90+

Regulatory Inspections supported by the team

300+

Group employees out of 3 continents

50+

Clinical Trial Sites currently active on UNITYdx™

2,200+

Aggregate Reports for Submission in 65+ countires

>30%

Savings typically achieved through automation

Soterius Expertise

We have a truly global presence capable of handling complete pharmacovigilance support and medical affairs across multiple geographies.

What Our Clients Say?

CONNECT WITH US

Head of Medical Affairs Division

Top 5 Pharma

"Experts – with Services and Technology Offerings"

quote-icon

Head of PV

Global Pharma Company

"Uber of Drug Safety"

quote-icon

Board Member

Top 10 Global Generic Company

"Cost-Effective through innovation, not just cost-cutting"

quote-icon

Head of Global Medical Affairs

Top 10 Global Pharma

"Re-Defining Pharmacoadherence"

quote-icon
Deploying an Inspection Ready AI System in PV
Deploying an Inspection Ready AI System in PV

Artificial intelligence in pharmacovigilance should not be assessed by how…

Is it Drug Induced Liver Injury (DILI), or something else?
Is it Drug Induced Liver Injury (DILI), or something else?

Ever faced a hepatic signal in a trial that looked…

Medication Errors & Patient Safety – Part I
Medication Errors & Patient Safety – Part I

Why Medication Errors Matter More Than We Think Medication errors…

Postmarketing Adverse Drug Experience (PADE) Inspections – Part IV
Postmarketing Adverse Drug Experience (PADE) Inspections – Part IV

Written Response May be considered in an FDA compliance decision.…

Post marketing Adverse Drug Experience (PADE) Inspections – Part III
Post marketing Adverse Drug Experience (PADE) Inspections – Part III

Legal Framework of PADE Inspections Scientific Literature Reports Determine: If…